Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 83,043 | 86,188 | 87,988 | 86,311 | 85,782 |
| Cost of Goods | 18,704 | 17,626 | 16,383 | 16,183 | 15,609 |
| Gross Profit | 64,339 | 68,562 | 71,605 | 70,128 | 70,173 |
| Operating Expenses | 71,847 | 73,439 | 99,916 | 66,261 | 65,703 |
| Operating Income | -6,804 | -4,251 | -27,928 | 4,050 | 5,079 |
| Interest Expense | 24 | 21 | 17 | 92 | 201 |
| Other Income | 6,442 | 4,129 | 1,674 | 3,927 | 3,404 |
| Pre-tax Income | -386 | -143 | -26,271 | 7,885 | 8,282 |
| Income Tax | 115 | -4,666 | -423 | -1,705 | 6,013 |
| Net Income Continuous | -501 | 4,523 | -25,848 | 9,590 | 2,269 |
| Net Income | $-501 | $4,523 | $-25,848 | $9,590 | $2,269 |
| EPS Basic Total Ops | -0.02 | 0.16 | -0.90 | 0.35 | 0.08 |
| EPS Basic Continuous Ops | -0.02 | 0.16 | -0.90 | 0.34 | 0.08 |
| EPS Diluted Total Ops | -0.02 | 0.15 | -0.90 | 0.32 | 0.08 |
| EPS Diluted Continuous Ops | -0.02 | 0.15 | -0.90 | 0.33 | 0.08 |
| EPS Diluted Before Non-Recurring Items | -0.02 | 0.15 | -0.20 | 0.32 | 0.08 |
| EBITDA(a) | $-3,893 | $-2,008 | $401 | $8,205 | $6,970 |